PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Co-cyprindiol (Cyprote acetate/ethinylestradiol)
Presentation Product Chemical substance Chapter Items dispensed
Co-cyprindiol 2000microgram/35microgram tablets
1306020C0AAAAAA
Co-cyprindiol Co-cyprindiol (Cyprote acetate/ethinylestradiol) Skin 9,657
Dianette tablets (Bayer)
1306020C0BBAAAA
Dianette Co-cyprindiol (Cyprote acetate/ethinylestradiol) Skin 6,771
Clairette 2000/35 tablets
1306020C0BFAAAA
Clairette Co-cyprindiol (Cyprote acetate/ethinylestradiol) Skin 1,373
Acnocin 2000microgram/35microgram tablets
1306020C0BCAAAA
Acnocin Co-cyprindiol (Cyprote acetate/ethinylestradiol) Skin No data available
Cicafem 2000/35 tablets
1306020C0BEAAAA
Cicafem Co-cyprindiol (Cyprote acetate/ethinylestradiol) Skin No data available
Dianette tablets (Mylan)
1306020C0BBABAA
Dianette Co-cyprindiol (Cyprote acetate/ethinylestradiol) Skin No data available
Diva 2000/35 tablets
1306020C0BDAAAA
Diva Co-cyprindiol (Cyprote acetate/ethinylestradiol) Skin No data available
Teragezza 2000microgram/35microgram tablets
1306020C0BGAAAA
Teragezza Co-cyprindiol (Cyprote acetate/ethinylestradiol) Skin No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.